Apotex asks Supreme Court to overturn Teva ‘Bendeka’ ruling

Apotex has asked the US Supreme Court to reconsider a US Court of Appeals for the Federal Circuit ruling upholding four of Teva Pharmaceutical’s cancer drug patents.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Generics

Bayer, Meda sue Apotex over nasal spray

12 October 2021 Bayer Healthcare and drug importer Meda Pharmaceuticals have sued generic manufacturer Apotex, alleging that its planned generic nasal spray infringes on Bayer’s Astepro patents.

Americas

Fed Circuit backs Eli Lilly in Apotex’s appeal over failed Alimta NDA

22 December 2020 The US Court of Appeals for the Federal Circuit yesterday, December 21, upheld Eli Lilly’s success in barring the sale of a copycat version of cancer treatment Alimta (pemetrexed disodium).

More on this story

Generics

Bayer, Meda sue Apotex over nasal spray

12 October 2021 Bayer Healthcare and drug importer Meda Pharmaceuticals have sued generic manufacturer Apotex, alleging that its planned generic nasal spray infringes on Bayer’s Astepro patents.

Americas

Fed Circuit backs Eli Lilly in Apotex’s appeal over failed Alimta NDA

More on this story

Generics

Bayer, Meda sue Apotex over nasal spray

12 October 2021 Bayer Healthcare and drug importer Meda Pharmaceuticals have sued generic manufacturer Apotex, alleging that its planned generic nasal spray infringes on Bayer’s Astepro patents.

Americas

Fed Circuit backs Eli Lilly in Apotex’s appeal over failed Alimta NDA